BLA/NDA/MAA Submissions and Commercialization

This course provides a practical introduction to regulatory affairs in clinical trials and global drug approval processes, with an emphasis on Biologics License Applications (BLA), New Drug Applications (NDA), and Marketing Authorization Applications (MAA).

Students will learn how regulatory professionals collaborate across clinical, quality, and commercial functions while interfacing with the U.S.

Food and Drug Administration and international regulatory agencies throughout the product development and approval lifecycle.

The curriculum covers the structure and key components of successful regulatory submissions, including regulatory documentation, compliance requirements, approval pathways, submission strategy, and commercialization planning for biotechnology products.

Learners will gain practical skills in cross-functional coordination, regulatory communication, strategic planning, and managing submission processes that support product approval and market readiness.

This course prepares students for careers in regulatory affairs, clinical development, regulatory submissions, and biotechnology commercialization within the pharmaceutical, biotechnology, and healthcare industries.